OBERWEIS ASSET MANAGEMENT INC/

Position in ARQT — Arcutis Biotherapeutics, Inc.

CIK 937886 LISLE, IL

Position in ARQT

as of Jun 30, 2026 · filed Aug 14, 2026 Compact

Position Value

$35,998,513

+$3,816,944 QoQ

Shares Held

1,372,941

+0.5% QoQ

Ownership

1.09%

of shares outstanding

% of Portfolio

0.75%

of 13F equity value

Holder Rank

#20

of 271 holders

Holding Since

Dec 2025

3 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

OBERWEIS ASSET MANAGEMENT INC/ holds $71,518,263 across 4 Biotechnology names. ARQT ranks #1 (50.3% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ARQT	Arcutis Biotherapeutics, Inc. This page	1,372,941	$35,998,513
2	HALO	Halozyme Therapeutics, Inc.	321,030	$25,127,018
3	CRMD	CorMedix Inc.	1,323,915	$10,392,732
4			293,670	$0

3 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$35,998,513	1,372,941	+0.5%	Shares	Sole	2026-08-14
2026-03-31	$32,181,569	1,365,941	+69.0%	Shares	Sole	2026-05-15
2025-12-31	$23,475,936	808,400	—	Shares	Sole	2026-02-17
No filing history on record for this holder in this stock.